Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy
Trial ID or NCT#
NCT02203565
Status
NOT RECRUITING
Purpose
This pilot clinical trial studies Dakin's solution in preventing radiation dermatitis in patients with breast cancer undergoing radiation therapy. Radiation dermatitis is a skin condition in which the affected skin becomes painful, red, itchy, and blistered. Dakin's solution may help reduce dermatitis caused by radiation therapy.
Official Title
Pilot Study to Investigate the Impact of Hypochlorite in the Prevention of Radiation Dermatitis
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Women with breast cancer who plan to undergo radiation therapy to the breast or chest wall - Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria:
- - Women with scleroderma or discoid lupus - Women with inflammatory breast cancer as evidenced by clinical assessment - Women with breast cancer involving the skin - Women who have undergone prior radiotherapy to the chest wall and/or breast
Investigator(s)
Sarah S. Donaldson, MD
Susan Knox
Contact us to find out if this trial is right for you.
Contact
Amanda Simmons
650-724-4606
View on ClinicalTrials.gov
